Cosmos Health (COSM) EBITDA Margin Growth (5y) (2019 - 2026)
Analysis
Cosmos Health (COSM) EBITDA Margin Growth (5y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -608.00 |
| Mar 31, 2026 | 273.00 |
| Dec 31, 2025 | -6,084.00 |
| Sep 30, 2025 | -1,856.00 |
| Jun 30, 2025 | -2,552.00 |
| Mar 31, 2025 | -770.00 |
| Dec 31, 2024 | -6,707.00 |
| Sep 30, 2024 | -1,701.00 |
| Jun 30, 2024 | -1,212.00 |
| Mar 31, 2024 | -1,053.00 |
| Dec 31, 2023 | -7,182.00 |
| Sep 30, 2023 | -2,312.00 |
| Jun 30, 2023 | -1,901.00 |
| Mar 31, 2023 | -1,973.00 |
| Dec 31, 2022 | -4,152.00 |
| Sep 30, 2022 | -238.00 |
| Jun 30, 2022 | 1,302.00 |
| Mar 31, 2022 | 5,065.00 |
| Dec 31, 2021 | -127.00 |
| Sep 30, 2021 | -420.00 |